83-3901-76 ［取扱停止］Anti-SARS-CoV-2 Spike NTD Antibody, Human IgG1 （MALS verified） 100ug SPD-S164-100ug
特徴
- 背景
- S protein has two functional regions, S1 and S2.
- S1 is composed of four domains, including N-amino-terminal domain （NTD） and receptor-binding domain （RBD）, and binds to host cell receptor ACE2.
- Compared with RBD antibody, the neutralization ability of NTD antibody is weak, most of which can recognize the three-dimensional conformation of viral protein.
- In the NTD region of mutant strains, there are a large number of amino acid deletion and insertion, as well as numerous point mutations, most of which can escape the recognition and neutralization of NTD antibody.
仕様
- 容量：100ug
- Source：S protein has two functional regions, S1 and S2. S1 is composed of four domains, including N-amino-terminal domain （NTD） and receptor-binding domain （RBD）, and binds to host cell receptor ACE2. Compared with RBD antibody, the neutralization ability of NTD antibody is weak, most of which can recognize the three-dimensional conformation of viral protein. In the NTD region of mutant strains, there are a large number of amino acid deletion and insertion, as well as numerous point mutations, most of which can escape the recognition and neutralization of NTD antibody.
- Species Reactivity：Human
- Host：HEK293
- Tag：Human IgG1 | Human Kappa
- Application：ELISA
- Molecule：Spike NTD
- Format：Liquid
- Conjugate：Unconjugated
- Endotoxin：1.0 EU per μg
- Purity：95％
- Buffer：PBS, pH7.4
- この商品は法規制を確認しておりません。（法規制によって販売できない場合もございます）
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL：06-6447-8641
- FAX：06-6447-8642
- E-mail：[email protected]
商品のバリエーション （サイズ違い・スペック違い・オプション品など）
| 商品イメージ | アズワン品番 商品名 |
|---|---|
|
83-3901-77
Anti-SARS-CoV-2 Spike NTD Antibody, Human IgG1 （MALS verified） 1mg
|
|
|
83-3901-76
Anti-SARS-CoV-2 Spike NTD Antibody, Human IgG1 （MALS verified） 100ug
|
よくあるご質問（FAQ）
掲載カタログ情報
| 掲載カタログ名 | 掲載ページ |
|---|